National Health Investors, Inc. (NHI)
NYSE: NHI · Real-Time Price · USD
66.28
+0.61 (0.93%)
Oct 16, 2026, 4:00 PM EDT - Market closed
National Health Investors Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, National Health Investors stock has a consensus rating of "Buy" and an average price target of $80.88. The average 1-year stock price forecast is 22.03% higher than the current stock price, while the lowest is $65 (-1.93%) and the highest is $90 (+35.79%).
Price Target: $80.88 (+22.03%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for National Health Investors stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BMO Capital | BMO Capital | Buy Maintains $80 | Buy | Maintains | $80 | +20.70% | Oct 5, 2026 |
| Janney Montgomery | Janney Montgomery | Buy Initiates $79 | Buy | Initiates | $79 | +19.19% | Sep 9, 2026 |
| Truist Financial | Truist Financial | Buy Maintains $81 → $80 | Buy | Maintains | $81 → $80 | +20.70% | Sep 2, 2026 |
| Wells Fargo | Wells Fargo | Hold Reiterates $79 → $78 | Hold | Reiterates | $79 → $78 | +17.68% | Sep 1, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $91 → $86 | Buy | Maintains | $91 → $86 | +29.75% | Aug 24, 2026 |
Financial Forecast
Revenue This Year
459.65M
from 379.29M
Increased by 21.19%
Revenue Next Year
485.92M
from 459.65M
Increased by 5.71%
EPS This Year
14.55
from 2.93
Increased by 396.65%
EPS Next Year
3.35
from 14.55
Decreased by -76.94%
EPS based on non-GAAP adjusted numbers.